Observational studyThe Lancet. Infectious diseases2024

Tolerability, safety, and immunogenicity of the novel oral polio vaccine type 2 in children aged 6 weeks to 59 months in an outbreak response campaign in The Gambia: an observational cohort study.

Adedapo O Bashorun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.